A double-blind randomized study assessing safety and efficacy following one-year adjunctive treatment with bitopertin, a glycine reuptake inhibitor, in Japanese patients with schizophrenia

This page shows the most recent Facebook posts that mention this research output.

Click here to find out how to access more activity.